Annual Meeting Archives

2016

Choosing the right development path for newly developed molecules (or choosing the right path for “older” molecules when plan A has failed to deliver)
Category:
Oral Delivery
Authors:
S. TINDAL (1)
Institutions:
(1) Catalent, U.S.A.
Circulating monocyte subsets in vascular injury following liposomal bisphosphonate treatment
Category:
Overcoming Biological Barriers in Drug Delivery
Authors:
G. GOLOMB (1), E. Grad (1), K. Zolotarevsky (1), D. Gutman (1)
Institutions:
(1) The Hebrew University of Jerusalem, Israel
Cisplatin-conjugated gold nanoparticles for improved radiotherapeutic effects in in vitro models of triple negative breast cancer
Category:
Preclinical Science Challenges to Drug Delivery
Authors:
S. HER (1), L. Cui (1), D. Jaffray (2), R. Bristow (2), C. Allen (1)
Institutions:
(1) University of Toronto, Canada; (2) University of Toronto, Princess Margaret Cancer Centre, Canada
Cleavable Gold Nanoclusters for High Drug Payload and Efficient Tumor Targeting
Category:
Local Drug Delivery
Authors:
W. MAO (1)
Institutions:
(1) Department of Medical Biomaterials Engineering, Kangwon National University, South Korea
Coating effects of mucoadhesive polymers on solid lipid nanoparticles for oral drug delivery
Category:
Oral Delivery
Authors:
P. RAMALINGAM (1), K. Ji Hee (1), K. Young Tag (1)
Institutions:
(1) Gachon University, South Korea
Coffee silverskin and hyaluronic acid as anti-wrinkles ingredients: An in vivo comparison study
Category:
Delivery Technologies in Cosmetics, Personal Care, and Household Products
Authors:
R. Matias (1), M. Ferreira (1), M. Amaral (2), M. Oliveira (3), F. Rodrigues (1)
Institutions:
(1) Inovapotek, Pharmaceutical Research & Development, Porto, Portugal, Portugal; (2) Faculty of Pharmacy, University of Porto, Porto, Portugal, Portugal; (3) Requimte, Faculty of Pharmacy, University of Oporto, Portugal
Coiled-coil functionalized liposomes for the targeting of liposomes for gene delivery
Category:
Oligonucleotide Delivery: New Applications and Opportunities
Authors:
E. OUDE BLENKE (1), J. van den Dikkenberg (1), B. van Kolck (2), A. Kros (2), E. Mastrobattista (1)
Institutions:
(1) Utrecht University, Netherlands; (2) Leiden University, Netherlands
Colloidal Mesoporous Silica Nanoparticles with Large-pore Sizes for Encapsulation of Various Proteins
Category:
Encapsulation and Controlled Release for Industrial Applications
Authors:
J. TU (1), A. Kros (1), P. Bomans (2), N. Sommerdijk (2), W. Jiskoot (1)
Institutions:
(1) Leiden University, Netherlands; (2) Eindhoven University of Technology, Netherlands
Combination chemotherapy of doxorubicin and paclitaxel against human liver cancer cells by self-solidifying polymeric drug delivery system
Category:
Local Drug Delivery
Authors:
N. NASONGKLA (1), N. Suwannakul (2), P. Nittayacharn (2)
Institutions:
(1) Department of Biomedical Engineering, Faculty of Engineering, Mahidol University, Thailand; (2) Department of Biomedical Engineering, Faculty of Engineering, Mahidol University, Thailand
Combination of a fluorescent dye with DPI formulations to improve in vivo imaging
Category:
Integration of Imaging and Drug Delivery
Authors:
V. BAGNACANI (1)
Institutions:
(1) Chiesi Farmaceutici, Italy
Combination of Nanoparticle-Delivered Sirna for Astrocyte Elevated Gene-1 (AEG-1) and All-Trans Retinoic Acid (ATRA): a Therapeutic Strategy for Hepatocellular Carcinoma (HCC)
Category:
Taking Stock of Progress and Challenges in Drug Delivery and Targeting
Authors:
K. EBEID (1), D. Sarkar (2), A. Salem (1), M. Akiel (2)
Institutions:
(1) University of Iowa, Pharmacy school, U.S.A.; (2) virginia commonwealth university, U.S.A.
Combinatorial mTORC2 RNAi and lapatanib for treatment of HER2-amplified breast cancer
Category:
Oligonucleotide Delivery: New Applications and Opportunities
Authors:
C. DUVALL (1), T. Werfel (1), D. Brantley-Sieders (1), M. Jackson (1), T. Kavanaugh (1), M. Morrison (1), D. Hicks (1), R. Cook (1)
Institutions:
(1) Vanderbilt University, U.S.A.
Combined administration of novel drug, NCL-240, and 2-DG in cancer cells
Category:
Physical Oncology: Modulating Tumor Microenvironment for Drug Delivery
Authors:
B. PATTNI (1), A. Jhaveri (1), A. Degterev (2), V. Torchilin (1), I. Dutta (1)
Institutions:
(1) Northeastern University, U.S.A.; (2) Tufts University, U.S.A.
Combining Lipophilic Prodrugs and Lipid Based Nanomedicine to Convert Injectable to Oral Chemotherapy
Category:
Oral Delivery
Authors:
C. PRESTIDGE (1)
Institutions:
(1) University of South Australia, Australia
Comparative Analysis of Polymeric Conjugates Containing First Generation Geldanamycin or Second Generation SNX-5422 as HSP90 Inhibitors
Category:
Parenteral Systemic Delivery of Biopharmaceuticals: Overcoming Product Development and Regulatory Challenges
Authors:
J. SUAREZ DEL PINO (1)
Institutions:
(1) University of Illinois at Chicago, U.S.A.
Comparative aspects of drug transporters in companion animals: Implications for drug delivery
Category:
Preclinical Science Challenges to Drug Delivery
Authors:
K. MEALEY (1)
Institutions:
(1) Washington State University, U.S.A.
Comparative studies on a novel testing method for the determination of disintegration time of orodispersible films.
Category:
Oral Delivery
Authors:
T. PHAM (1), D. Terry (2), D. Lowry (1), D. Kirby (1)
Institutions:
(1) Aston University, United Kingdom; (2) Birmingham Children Hospital, United Kingdom
Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via ?-? Stacking Stabilized Polymeric Micelles
Category:
Integration of Imaging and Drug Delivery
Authors:
R. VAN DER MEEL (1), Y. Shi (2), B. Theek (3), E. Oude Blenke (4), E. Pieters (4), M. Fens (5), J. Ehling (3), R. Schiffelers (5), G. Storm (4), C. van Nostrum (4), T. Lammers (3), W. Hennink (4)
Institutions:
(1) University of British Columbia / University Medical Center Utrecht, Canada; (2) South China University of Technology, China; (3) RWTH Aachen University, Germany; (4) Utrecht University, Netherlands; (5) University Medical Center Utrecht, Netherlands
Composite Nanotherapeutics for Long Term Ocular Delivery of Macromolecules
Category:
Ocular Drug Delivery
Authors:
V. AGRAHARI (1), V. Agrahari (2), W. Hung (3), L. Christenson (3), A. Mitra (2)
Institutions:
(1) University of Missouri-Kanss City, U.S.A.; (2) University of Missouri Kansas City, U.S.A.; (3) University of Kansas Medical Center, U.S.A.
Compositional and Performance Stability of a Fully Formulated Ethylcellulose Barrier Membrane Coating System
Category:
Oral Delivery
Authors:
A. RAJABI-SIAHBOOMI (1), L. Martin (1), J. Teckoe (1)
Institutions:
(1) Colorcon, U.S.A.
Consideration of Dynamic Factors for Cancer Models and Modeling
Category:
Predictive Modeling in Delivery and Targeting (Scaling: Mouse to Man
Authors:
Probability of Reaching Targets
Institutions:
Stochastic Process in System Distribution)
Considerations in the Use of the Beagle Dog as a Preclinical Species in Assessing Bioperformance and Oral Sustained Release Technology Development
Category:
Comparative Pharmacokinetics in Preclinical Sciences
Authors:
P. WALSH (1)
Institutions:
(1) Merck & Co., Inc., U.S.A.
Continuous solid dispersions using co-processed Nesulin-solubulizers
Category:
Manufacture, Characterization, Stability, and Regulatory Aspects
Authors:
D. DOUROUMIS (1), M. Maniruzamman (2), A. Nair (3)
Institutions:
(1) University of Greenwch, United Kingdom; (2) University of Sussex, United Kingdom; (3) Fuji Chemical Industry Co., Ltd., Japan
Continuous twin-screw granulation for enhancing the dissolution of poorly water soluble drug
Category:
Manufacture, Characterization, Stability, and Regulatory Aspects
Authors:
D. DOUROUMIS (1), M. Maniruzamman (1), A. Nair (2), N. Scoutaris (1)
Institutions:
(1) University of Greenwich, United Kingdom; (2) Fuji Chemical Industry Co., Ltd., Japan
Controlled and sequential delivery of fluorophores from 3D Printed alginate-PLGA devices
Category:
Tissue Engineering
Authors:
A. DO (1), A. Akkouch (1), B. Green (1), I. Ozbolat (1), A. Debaneh (1), A. Salem (1)
Institutions:
(1) The University of Iowa, U.S.A.